<- Go Home

Microbix Biosystems Inc.

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Market Cap

CAD 67.8M

Volume

64.7K

Cash and Equivalents

CAD 13.0M

EBITDA

CAD 5.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CAD 15.4M

Profit Margin

60.61%

52 Week High

CAD 0.52

52 Week Low

CAD 0.29

Dividend

N/A

Price / Book Value

2.39

Price / Earnings

19.42

Price / Tangible Book Value

2.81

Enterprise Value

CAD 61.2M

Enterprise Value / EBITDA

11.38

Operating Income

CAD 3.9M

Return on Equity

13.30%

Return on Assets

6.62

Cash and Short Term Investments

CAD 13.0M

Debt

CAD 6.4M

Equity

CAD 28.3M

Revenue

CAD 25.4M

Unlevered FCF

CAD 1.3M

Sector

Biotechnology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches